During the past decade, St Jans Gasthuis conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St Jans Gasthuis" #1 sponsor was "Borstkanker Onderzoek Groep" with 1 trials, followed by "Dutch Colorectal Cancer Group" with 1 trials sponsored, "Ferring Pharmaceuticals" with 1 trials sponsored, "Lonneke van de Poll-Franse" with 1 trials sponsored and "Maastricht University Medical Center" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St Jans Gasthuis" #1 collaborator was "Borstkanker Onderzoek Groep" with 1 trials as a collaborator, "Catharina Ziekenhuis Eindhoven" with 1 trials as a collaborator, "Comprehensive Cancer Centre The Netherlands" with 1 trials as a collaborator, "Dutch Cancer Society" with 1 trials as a collaborator and "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "St Jans Gasthuis" are "Ovarian Cancer" (2 trials), "Acute Thrombosis of Deep Veins of Proximal Lower Extremity" (1 trials), "Asherman Syndrome" (1 trials), "Breast Neoplasm Female" (1 trials) and "Colorectal Cancer" (1 trials). Many other conditions were trialed in "St Jans Gasthuis" in a lesser frequency.

Most popular intervention types in "St Jans Gasthuis" are "Device" (3 trials), "Other" (2 trials), "Drug" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "CDK 4/6 inhibitor" (1 trials), "Ekos endowave system thrombolysis" (1 trials), "Fulvestrant" (1 trials), "Non-Steroidal Aromatase Inhibitor" (1 trials) and "Opportunistic Salpingectomy" (1 trials). Other intervention names were less common.

The vast majority of trials in "St Jans Gasthuis" are 5 trials for "Female" genders, 2 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "St Jans Gasthuis". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 3 completed trials in St Jans Gasthuis, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in St Jans Gasthuis, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".